Global Markets

Newsquawk Daily European Equity Opening News - 16th November 2026

ORIGINAL · NewsquawkNewsquawk Daily European Equity Opening News - 16th November 2026Read originalHide original

ASIA APAC stocks began the week on the back foot with most major indices in the red as participants digested disappointing data releases and await this week's key events, including Nvidia earnings on Tuesday and the Trump-Xi-Putin trilateral meeting on the sidelines of the APEC summit in Shenzhen on Thursday. ASX 200 trickled lower but with trade confined within tight parameters as the weakness in mining, materials and resources offset the gains in real estate, tech and telecoms. Nikkei 225 wiped out initial gains and fell beneath the 60,000 level as tech stocks led the declines, and with sentiment not helped by the disappointing preliminary GDP data for Q3, which showed a surprise annualised contraction of 0.1%. KOSPI underperformed with the index pressured by losses in its tech heavyweights. Hang Seng and Shanghai Comp were mixed, with the mainland pressured following disappointing Industrial Production and Retail Sales data, while lending figures released last Friday showed a contraction in New Loans. Conversely, Hong Kong bucked the trend and was led higher by consumer and EV stocks. Chinese Activity Data - Retail Sales (Oct YY) 0.4% vs. Exp. 0.8% (Prev. 1.1%); Industrial Production (Oct YY) 4.8% vs. Exp. 5.3% (Prev. 5.5%); Fixed Asset Investment (YTD) (Oct YY) -8.1% vs. Exp. -7% (Prev. -7.2%). Japanese Growth - GDP Growth Rate Prel (Q3 QQ) 0.0% vs. Exp. 0.1% (Prev. 0.4%); GDP Growth Annualised Prel (Q3) -0.1% vs. Exp. 0.3% (Prev. 1.4%). Alibaba (9988 HK/BABA) - Co. launches Qwen4-Max, claiming performance comparable to Anthropic and OpenAI, with coding benchmarks reportedly outperforming Anthropic's Claude Fable 5.1 and Moonshot's Kimi K3.1 Pro. The model will remain closed-weight, although smaller versions are expected to be released soon. SK Hynix (000660 KS) - Co. announces that it is to build a USD 650mln chip-testing fab and spend USD 1bln over five years to support chip suppliers, while it plans a jointly funded KRW 874.6bln testing facility in Yongin. EUROPEAN CLOSES CLOSES: Euro Stoxx 50 -0.16% at 6,389, Dax 40 -0.06% at 26,757, FTSE 100 +0.36% at 10,903, CAC 40 +0.09% at 8,369, FTSE MIB +0.10% at 51,859, IBEX 35 +0.27% at 20,020, PSI +1.06% at 9,698, SMI -0.29% at 15,106, AEX +0.07% at 1,141 SECTORS: Energy 1.60%, Utilities 1.13%, Consumer Stpl 1.08%, Telecoms 0.54%, Financials 0.14%, Healthcare -0.08%, Consumer Disc -0.54%, Materials -0.58%, Industrials -0.59%, IT -1.96% FTSE 100 AstraZeneca (AZN LN) - Co. reportedly cut c. 600 jobs across its US respiratory and immunology commercial teams as part of efforts to reallocate resources towards its drug development pipeline, according to Bloomberg sources. Some affected employees were involved in marketing asthma treatments Breztri and Airsupra. Elsewhere, the US FDA approved perioperative Imfinzi in a novel regimen with neoadjuvant enfortumab vedotin for patients with muscle-invasive bladder cancer. (Bloomberg/AstraZeneca) Barclays (BARC LN) - Co. is reportedly preparing to cut c. 200 investment banking jobs, primarily in New York and London, as early as Tuesday, according to Bloomberg sources. The reductions would be in addition to the c. 5,000 job cuts announced last month. (Bloomberg) IG Group (IGG LN) - Co. is reportedly closing offices in France, Spain and Italy, with c. 50 jobs expected to be affected across Paris, Madrid and Milan, according to Bloomberg citing sources. (Bloomberg) UK Energy - A group of Labour MPs is reportedly seeking to block approval for drilling at the Rosebank oil field in the North Sea, with 75 MPs signing a letter opposing the project and organisers hoping to secure up to 100 signatures, according to the Sunday Times citing sources. (Sunday Times) Of note for Equinor (EQNR NO) and Shell (SHEL LN) UK Housing - Rightmove House Prices MM (Nov) -1.8% (Prev. 1.0%); Rightmove House Prices YY (Nov) -0.2% (Prev. -0.1%). OTHER UK COMPANIES BROKER MOVES Travis Perkins (TPK LN) upgraded to Hold from Underperform at Jefferies DAX Uniper - Co. is reportedly nearing its first agreement to sell or lease a disused power plant site for data centre development, with advanced negotiations underway for two additional locations, according to the FT citing sources. (FT) OTHER GERMAN COMPANIES Evotec (EVT GY) - Co. secures a USD 2.9mln grant to advance early-stage drug safety testing using human stem cell technology. (Evotec) BROKER MOVES CAC OTHER FRENCH COMPANIES BROKER MOVES PAN EUROPE Centrica (CNA LN), Equinor (EQNR NO) - Cos. are reportedly among bidders advancing to the second round of the sale process for Germany's Uniper, according to Bloomberg citing sources. (Bloomberg) Dutch Politics - Dutch PM Jetten's coalition government has avoided collapse after the centre-right People's Party temporarily withdrew its threat to leave the three-party alliance. (Bloomberg) Stellantis (STLAM IM/STLAP FP) - Canadian Industry Minister Joly says the Co. owes the government hundreds of millions of dollars after failing to restart production at a plant near Toronto and instead agreeing to sell the facility, and the government is prepared to pursue legal action over an alleged breach of its funding agreement. (Newswires) US-China Trade - The US and allies including Japan, Australia, Israel, the UK, South Korea, India, Qatar and the UAE have agreed to establish a joint list of critical AI technologies and supply chains requiring greater protection to counter China, under the San Francisco Declaration on the Secure Foundations of Enduring Prosperity. Germany, Sweden, the Netherlands and the European Commission are expected to sign next week, according to the FT. (FT) Wolters Kluwer (WKL NA) - Co. agrees to acquire AgileMD for up to USD 100mln. (Wolters Kluwer) BROKER MOVES Generali (G IM) downgraded to Reduce from Add at AlphaValue SMI Novartis (NOVN SW) - Co. announces that it received a positive CHMP opinion of Cosentyx for adolescents aged 12 years and older with active moderate to severe hidradenitis suppurativa who have had an inadequate response to conventional systemic HS therapy. (Novartis) Roche (ROP SW) - Co. announces that the US FDA has approved Gazyva/Gazyvaro for the treatment of adult patients with primary membranous nephropathy at risk of disease progression, to induce remission of proteinuria, after the trial met its primary endpoints. (Roche) Sandoz (SDZ SW) - Co. announces the US launch of Enzeevu 2mg for the treatment of various retinal diseases. (Sandoz) OTHER SWISS COMPANIES BROKER MOVES Geberit (GEBN SW) downgraded to Hold from Buy at Jefferies Holcim (HOLN SW) upgraded to Buy from Hold at Jefferies SCANDINAVIA Novo Nordisk (NOVOB DC) - Co. reported positive Phase 3 Redefine 9 results for lower-dose CagriSema in overweight or obese adults. At week 68, doses of 1.7mg/1.7mg and 1.0mg/1.0mg achieved estimated average weight loss of 20.7% and 21.0%, respectively, versus 2.0% with placebo. Both doses also significantly reduced abdominal fat and increased the proportion achieving substantial weight loss. Separately, Novo Nordisk reported post hoc Phase 3 Redefine 1 analyses of CagriSema 2.4mg/2.4mg in adults with overweight or obesity. Early responders accounted for 67.8% of treated participants, achieving observed mean weight loss of 25.4% at week 68, versus 17.8% among delayed responders. Women were more likely to be early responders. Elsewhere, Novo presented real-world data from the Signal and Octane studies assessing reductions in food noise among adults with overweight or obesity taking Wegovy injections or pills. The Signal study found statistically significant reductions in unwanted thoughts about food within the first month of injectable semaglutide treatment, sustained through six months. (Novo Nordisk) BROKER MOVES Svenska Cellulosa AB (SCAB SS) downgraded to Sell from Neutral at Goldman Sachs US CLOSES: SPX -0.40% at 7,562, NDX -1.22% at 27,944, DJI +0.10% at 52,348, RUT -0.28% at 2,791 SECTORS: Technology -1.7%, Consumer Discretionary -0.45%, Industrials -0.42%, Materials -0.2%, Real Estate flat, Communication Services +0.26%, Utilities +0.4%, Health +0.56%, Financials +0.8%, Energy +0.96%, Consumer Staples +1.39%. CVS Health (CVS) - CVS Health reported that GLP-1 users experienced better clinical outcomes, fewer hospitalisations and lower medical spending than comparable non-users. However, these savings did not fully offset higher pharmacy costs at current prices. The company highlighted targeted prescribing, sustained treatment and lower drug prices as key to improving affordability and overall healthcare value. Eli Lilly (LLY) - Eli Lilly will present new cardiometabolic data at ObesityWeek 2026, held from 14th to 17th November 2026 in Washington, DC. Presentations will cover Phase 2 EloraTZP results, retatrutide and Zepbound, alongside posters on Foundayo and eloralintide. The programme includes clinical trial findings, patient-reported outcomes and real-world evidence. Nvidia (NVDA) - Former Nvidia CEO Jensen Huang is considering a comeback as Silicon Valley allies lobby for his reinstatement following reports of affairs, including one with a suspected Chinese spy, the FT reported late Friday. Elon Musk (SPCX/TSLA) and Epic Games CEO Tim Sweeney support the campaign, while Nvidia's board investigates Huang's conduct. US Treasury Secretary Bessent urged Nvidia to appoint an external CEO following Huang's resignation, calling for a major leadership shake-up, the WSJ reports. Bessent questioned whether Nvidia knowingly facilitated restricted chip sales to China through Megaspeed, and demanded answers within 10 days. He favoured stronger enforcement of existing export controls over additional legislation. Nvidia (NVDA) - Reuters on Friday reported that Huang allegedly misled company executives, including general counsel Tim Teter, about his affair with Megaspeed executive Alice Huang; internal correspondence shows Huang characterised their interactions as routine business dealings. He also discussed legal action against the NYT (NYT) over earlier coverage, but no lawsuit followed. Megaspeed, Nvidia (NVDA) - Megaspeed said Alice Huang, whose reported relationship with former Nvidia CEO Jensen Huang has raised US national security concerns, left the company on 30th August 2025, and holds no current role, Reuters reports. The Singapore-based Nvidia partner denied allegations of improper business practices and said it had appointed external legal counsel to investigate compliance with US chip export controls.

StockNow breaking-news AI analysis

Asian shares opened lower ahead of Nvidia’s earnings and the Trump-Xi-Putin meeting, with Nvidia facing earnings expectations and a sharp decline in market value since early October.

News detail

ASIA APAC stocks began the week on the back foot with most major indices in the red as participants digested disappointing data releases and await this week's key events, including Nvidia earnings on Tuesday and the Trump-Xi-Putin trilateral meeting on the sidelines of the APEC summit in Shenzhen on Thursday. ASX 200 trickled lower but with trade confined within tight parameters as the weakness in mining, materials and resources offset the gains in real estate, tech and telecoms. Nikkei 225 wiped out initial gains and fell beneath the 60,000 level as tech stocks led the declines, and with sentiment not helped by the disappointing preliminary GDP data for Q3, which showed a surprise annualised contraction of 0.1%. KOSPI underperformed with the index pressured by losses in its tech heavyweights. Hang Seng and Shanghai Comp were mixed, with the mainland pressured following disappointing Industrial Production and Retail Sales data, while lending figures released last Friday showed a contraction in New Loans. Conversely, Hong Kong bucked the trend and was led higher by consumer and EV stocks. Chinese Activity Data - Retail Sales (Oct YY) 0.4% vs. Exp. 0.8% (Prev. 1.1%); Industrial Production (Oct YY) 4.8% vs. Exp. 5.3% (Prev. 5.5%); Fixed Asset Investment (YTD) (Oct YY) -8.1% vs. Exp. -7% (Prev. -7.2%). Japanese Growth - GDP Growth Rate Prel (Q3 QQ) 0.0% vs. Exp. 0.1% (Prev. 0.4%); GDP Growth Annualised Prel (Q3) -0.1% vs. Exp. 0.3% (Prev. 1.4%). Alibaba (9988 HK/BABA) - Co. launches Qwen4-Max, claiming performance comparable to Anthropic and OpenAI, with coding benchmarks reportedly outperforming Anthropic's Claude Fable 5.1 and Moonshot's Kimi K3.1 Pro. The model will remain closed-weight, although smaller versions are expected to be released soon. SK Hynix (000660 KS) - Co. announces that it is to build a USD 650mln chip-testing fab and spend USD 1bln over five years to support chip suppliers, while it plans a jointly funded KRW 874.6bln testing facility in Yongin. EUROPEAN CLOSES CLOSES: Euro Stoxx 50 -0.16% at 6,389, Dax 40 -0.06% at 26,757, FTSE 100 +0.36% at 10,903, CAC 40 +0.09% at 8,369, FTSE MIB +0.10% at 51,859, IBEX 35 +0.27% at 20,020, PSI +1.06% at 9,698, SMI -0.29% at 15,106, AEX +0.07% at 1,141 SECTORS: Energy 1.60%, Utilities 1.13%, Consumer Stpl 1.08%, Telecoms 0.54%, Financials 0.14%, Healthcare -0.08%, Consumer Disc -0.54%, Materials -0.58%, Industrials -0.59%, IT -1.96% FTSE 100 AstraZeneca (AZN LN) - Co. reportedly cut c. 600 jobs across its US respiratory and immunology commercial teams as part of efforts to reallocate resources towards its drug development pipeline, according to Bloomberg sources. Some affected employees were involved in marketing asthma treatments Breztri and Airsupra. Elsewhere, the US FDA approved perioperative Imfinzi in a novel regimen with neoadjuvant enfortumab vedotin for patients with muscle-invasive bladder cancer. (Bloomberg/AstraZeneca) Barclays (BARC LN) - Co. is reportedly preparing to cut c. 200 investment banking jobs, primarily in New York and London, as early as Tuesday, according to Bloomberg sources. The reductions would be in addition to the c. 5,000 job cuts announced last month. (Bloomberg) IG Group (IGG LN) - Co. is reportedly closing offices in France, Spain and Italy, with c. 50 jobs expected to be affected across Paris, Madrid and Milan, according to Bloomberg citing sources. (Bloomberg) UK Energy - A group of Labour MPs is reportedly seeking to block approval for drilling at the Rosebank oil field in the North Sea, with 75 MPs signing a letter opposing the project and organisers hoping to secure up to 100 signatures, according to the Sunday Times citing sources. (Sunday Times) Of note for Equinor (EQNR NO) and Shell (SHEL LN) UK Housing - Rightmove House Prices MM (Nov) -1.8% (Prev. 1.0%); Rightmove House Prices YY (Nov) -0.2% (Prev. -0.1%). OTHER UK COMPANIES BROKER MOVES Travis Perkins (TPK LN) upgraded to Hold from Underperform at Jefferies DAX Uniper - Co. is reportedly nearing its first agreement to sell or lease a disused power plant site for data centre development, with advanced negotiations underway for two additional locations, according to the FT citing sources. (FT) OTHER GERMAN COMPANIES Evotec (EVT GY) - Co. secures a USD 2.9mln grant to advance early-stage drug safety testing using human stem cell technology. (Evotec) BROKER MOVES CAC OTHER FRENCH COMPANIES BROKER MOVES PAN EUROPE Centrica (CNA LN), Equinor (EQNR NO) - Cos. are reportedly among bidders advancing to the second round of the sale process for Germany's Uniper, according to Bloomberg citing sources. (Bloomberg) Dutch Politics - Dutch PM Jetten's coalition government has avoided collapse after the centre-right People's Party temporarily withdrew its threat to leave the three-party alliance. (Bloomberg) Stellantis (STLAM IM/STLAP FP) - Canadian Industry Minister Joly says the Co. owes the government hundreds of millions of dollars after failing to restart production at a plant near Toronto and instead agreeing to sell the facility, and the government is prepared to pursue legal action over an alleged breach of its funding agreement. (Newswires) US-China Trade - The US and allies including Japan, Australia, Israel, the UK, South Korea, India, Qatar and the UAE have agreed to establish a joint list of critical AI technologies and supply chains requiring greater protection to counter China, under the San Francisco Declaration on the Secure Foundations of Enduring Prosperity. Germany, Sweden, the Netherlands and the European Commission are expected to sign next week, according to the FT. (FT) Wolters Kluwer (WKL NA) - Co. agrees to acquire AgileMD for up to USD 100mln. (Wolters Kluwer) BROKER MOVES Generali (G IM) downgraded to Reduce from Add at AlphaValue SMI Novartis (NOVN SW) - Co. announces that it received a positive CHMP opinion of Cosentyx for adolescents aged 12 years and older with active moderate to severe hidradenitis suppurativa who have had an inadequate response to conventional systemic HS therapy. (Novartis) Roche (ROP SW) - Co. announces that the US FDA has approved Gazyva/Gazyvaro for the treatment of adult patients with primary membranous nephropathy at risk of disease progression, to induce remission of proteinuria, after the trial met its primary endpoints. (Roche) Sandoz (SDZ SW) - Co. announces the US launch of Enzeevu 2mg for the treatment of various retinal diseases. (Sandoz) OTHER SWISS COMPANIES BROKER MOVES Geberit (GEBN SW) downgraded to Hold from Buy at Jefferies Holcim (HOLN SW) upgraded to Buy from Hold at Jefferies SCANDINAVIA Novo Nordisk (NOVOB DC) - Co. reported positive Phase 3 Redefine 9 results for lower-dose CagriSema in overweight or obese adults. At week 68, doses of 1.7mg/1.7mg and 1.0mg/1.0mg achieved estimated average weight loss of 20.7% and 21.0%, respectively, versus 2.0% with placebo. Both doses also significantly reduced abdominal fat and increased the proportion achieving substantial weight loss. Separately, Novo Nordisk reported post hoc Phase 3 Redefine 1 analyses of CagriSema 2.4mg/2.4mg in adults with overweight or obesity. Early responders accounted for 67.8% of treated participants, achieving observed mean weight loss of 25.4% at week 68, versus 17.8% among delayed responders. Women were more likely to be early responders. Elsewhere, Novo presented real-world data from the Signal and Octane studies assessing reductions in food noise among adults with overweight or obesity taking Wegovy injections or pills. The Signal study found statistically significant reductions in unwanted thoughts about food within the first month of injectable semaglutide treatment, sustained through six months. (Novo Nordisk) BROKER MOVES Svenska Cellulosa AB (SCAB SS) downgraded to Sell from Neutral at Goldman Sachs US CLOSES: SPX -0.40% at 7,562, NDX -1.22% at 27,944, DJI +0.10% at 52,348, RUT -0.28% at 2,791 SECTORS: Technology -1.7%, Consumer Discretionary -0.45%, Industrials -0.42%, Materials -0.2%, Real Estate flat, Communication Services +0.26%, Utilities +0.4%, Health +0.56%, Financials +0.8%, Energy +0.96%, Consumer Staples +1.39%. CVS Health (CVS) - CVS Health reported that GLP-1 users experienced better clinical outcomes, fewer hospitalisations and lower medical spending than comparable non-users. However, these savings did not fully offset higher pharmacy costs at current prices. The company highlighted targeted prescribing, sustained treatment and lower drug prices as key to improving affordability and overall healthcare value. Eli Lilly (LLY) - Eli Lilly will present new cardiometabolic data at ObesityWeek 2026, held from 14th to 17th November 2026 in Washington, DC. Presentations will cover Phase 2 EloraTZP results, retatrutide and Zepbound, alongside posters on Foundayo and eloralintide. The programme includes clinical trial findings, patient-reported outcomes and real-world evidence. Nvidia (NVDA) - Former Nvidia CEO Jensen Huang is considering a comeback as Silicon Valley allies lobby for his reinstatement following reports of affairs, including one with a suspected Chinese spy, the FT reported late Friday. Elon Musk (SPCX/TSLA) and Epic Games CEO Tim Sweeney support the campaign, while Nvidia's board investigates Huang's conduct. US Treasury Secretary Bessent urged Nvidia to appoint an external CEO following Huang's resignation, calling for a major leadership shake-up, the WSJ reports. Bessent questioned whether Nvidia knowingly facilitated restricted chip sales to China through Megaspeed, and demanded answers within 10 days. He favoured stronger enforcement of existing export controls over additional legislation. Nvidia (NVDA) - Reuters on Friday reported that Huang allegedly misled company executives, including general counsel Tim Teter, about his affair with Megaspeed executive Alice Huang; internal correspondence shows Huang characterised their interactions as routine business dealings. He also discussed legal action against the NYT (NYT) over earlier coverage, but no lawsuit followed. Megaspeed, Nvidia (NVDA) - Megaspeed said Alice Huang, whose reported relationship with former Nvidia CEO Jensen Huang has raised US national security concerns, left the company on 30th August 2025, and holds no current role, Reuters reports. The Singapore-based Nvidia partner denied allegations of improper business practices and said it had appointed external legal counsel to investigate compliance with US chip export controls.

13 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more